The four- to five-day technical-level programme takes an in-depth look at cytogenic dosimetry and includes topics such as: the basics of biological effects of ionizing radiation; the basics of ...
[12] This trial was designed to assess cytogenic response and time to disease progression, as requested by FDA, and the protocol demonstrated a working relationship between FDA and Novartis to ...
Darzalex (daratumumab) is a monoclonal antibody drug currently approved for both refractory and new multiple myeloma. It’s available in intravenous and subcutaneous formulations.